Financial Performance - Revenue for Q1 2025 was CNY 323,208,398.97, a decrease of 2.48% compared to CNY 331,433,693.21 in the same period last year[5] - Net profit attributable to shareholders was CNY 8,735,826.00, down 5.23% from CNY 9,217,774.06 year-on-year[5] - Basic earnings per share decreased by 5.26% to CNY 0.0126 from CNY 0.0133 in the previous year[5] - The net profit for the current period is 8,523,324.78, a decrease from 9,416,166.22 in the previous period, representing a decline of approximately 9.5%[18] - The total profit before tax for the current period is 10,584,073.69, down from 12,636,014.27 in the previous period, reflecting a decrease of approximately 16.2%[18] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 3,020,438,868.19, a decline of 3.21% from CNY 3,120,730,080.09 at the end of the previous year[5] - Total assets decreased to ¥3,020,438,868.19 from ¥3,120,730,080.09, reflecting a contraction in the asset base[15] - Total liabilities decreased to ¥1,509,325,345.85 from ¥1,628,765,841.91, indicating a reduction in financial obligations[15] - The company's equity increased to ¥1,511,113,522.34 from ¥1,491,964,238.18, reflecting a strengthening of the financial position[15] Cash Flow - Cash flow from operating activities improved significantly to CNY 44,276,922.48, compared to a negative cash flow of CNY -84,524,939.22 in the same period last year[5] - Operating cash flow for the current period is 44,276,922.48, a recovery from a negative cash flow of -84,524,939.22 in the previous period[20] - Cash and cash equivalents decreased to ¥356,224,393.26 from ¥591,707,066.76, indicating a potential liquidity concern[13] - Cash and cash equivalents at the end of the period amount to 256,696,106.13, down from 344,709,538.74 at the end of the previous period[20] Investment and Income - The company reported a 41.35% increase in investment income, reaching CNY 8,735,826.00 due to higher short-term investment returns[9] - The company reported an investment income of ¥17,864,194.59, up from ¥12,638,345.02, suggesting successful investment strategies[17] - Other income rose by 108.55% to CNY 393,861.85, primarily due to increased government subsidies received[9] - The company incurred a total investment cash outflow of 168,037,404.84, compared to 97,498,289.19 in the previous period, indicating increased investment activity[20] Operational Efficiency - Total operating revenue for the current period was ¥323,208,398.97, a decrease of 2.7% compared to ¥331,433,693.21 in the previous period[17] - Total operating costs amounted to ¥329,748,694.56, down from ¥333,233,726.03, reflecting a cost reduction strategy[17] - Operating costs included ¥264,571,068.07 in operating expenses, which decreased from ¥273,002,249.51, indicating improved operational efficiency[17] - Research and development expenses increased to ¥6,153,462.21 from ¥5,453,804.36, highlighting a commitment to innovation[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 108,130[11] - The company’s equity attributable to shareholders increased by 1.32% to CNY 1,489,102,385.08 compared to CNY 1,469,738,512.43 at the end of the previous year[5] Future Strategy - The company plans to focus on market expansion and new product development as part of its future strategy[17] Comprehensive Income - The total comprehensive income for the current period is 136,705,263.92, significantly higher than 16,099,045.84 in the previous period[18] - The company reported a significant increase in other comprehensive income after tax, totaling 128,181,939.14, compared to 6,682,879.62 in the previous period[18] Mergers and Acquisitions - The company has not executed any mergers or acquisitions during the reporting period, with no net profit reported from merged entities[18]

Financial Performance - The company's operating revenue for Q1 2025 was CNY 185,591,983.95, representing a 21.26% increase compared to CNY 153,058,271.42 in the same period last year[4] - Net profit attributable to shareholders increased by 40.10% to CNY 45,793,170.61 from CNY 32,684,974.03 year-on-year[4] - Basic and diluted earnings per share both rose by 40.00% to CNY 0.14 from CNY 0.10[4] - Operating profit for Q1 2025 was ¥53,738,813.23, up 43.4% from ¥37,509,072.47 in Q1 2024[21] - Net profit for Q1 2025 was ¥46,868,712.96, representing a 43.2% increase from ¥32,730,039.82 in Q1 2024[21] - Earnings per share for Q1 2025 was ¥0.14, compared to ¥0.10 in Q1 2024[22] Cash Flow - The net cash flow from operating activities surged by 589.62% to CNY 55,507,117.33, up from CNY 8,048,893.69 in the previous year[4] - Cash flow from operating activities for Q1 2025 was ¥55,507,117.33, significantly higher than ¥8,048,893.69 in Q1 2024[25] - The company reported a net cash outflow from investing activities of ¥9,687,122.47 in Q1 2025[25] - Total cash inflow from financing activities amounted to $1,000,000.00, while cash outflow totaled $47,227,623.22, resulting in a net cash flow of -$46,227,623.22[27] - The net increase in cash and cash equivalents was -$558,340.99, with a beginning balance of $169,447,913.66, leading to an ending balance of $168,889,572.67[27] - The cash flow from financing activities showed a significant increase in outflows compared to the previous period, which had outflows of $30,708,485.27[27] - The impact of exchange rate changes on cash and cash equivalents was -$150,712.63[27] Assets and Liabilities - Total assets decreased by 2.79% to CNY 1,680,186,414.91 from CNY 1,728,380,749.86 at the end of the previous year[5] - Total liabilities decreased from ¥463,314,446.90 in the previous period to ¥376,106,697.83[18] - Current liabilities decreased to ¥226,284,989.18 from ¥291,503,720.47, a decrease of about 22.4%[17] - Long-term borrowings decreased to ¥118,508,000.00 from ¥139,308,000.00, a reduction of approximately 14.9%[17] Shareholder Information - The total number of shareholders at the end of the reporting period is 16,520[11] - The largest shareholder, Yan Yiyi, holds 77,192,080 shares, representing 23.58% of the total shares[11] - The company has a total of 4,000,000 shares held by Yan Maolin through a credit securities account[12] - There are no significant changes in the participation of major shareholders in margin financing and securities lending activities[12] Research and Development - Research and development expenses decreased by 34.97%, mainly due to reduced outsourcing and personnel costs[8] - Research and development expenses for Q1 2025 were ¥7,660,759.12, down from ¥11,781,100.15 in Q1 2024[21] Other Financial Metrics - The weighted average return on equity increased by 0.87 percentage points to 3.57% compared to 2.70% at the end of the previous year[5] - Shareholders' equity attributable to the parent company increased by 3.01% to CNY 1,298,022,359.19 from CNY 1,260,084,487.42[5] - Accounts receivable increased to ¥39,679,124.70 from ¥32,909,369.27, indicating a growth of approximately 20.5%[16] - Inventory decreased to ¥118,406,392.38 from ¥131,843,548.31, a decline of about 10.2%[16] - The company recognized a government subsidy of CNY 868,215.62, which is expected to have a continuous impact on its profits[6] - Sales expenses increased to ¥43,626,154.81 in Q1 2025 from ¥39,746,999.05 in Q1 2024[21] Accounting Standards - The company did not apply new accounting standards starting from 2025[27]

Financial Performance - The company's operating revenue for Q1 2025 was CNY 309,592,187.60, a decrease of 26.58% compared to CNY 421,698,974.76 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 18,036,331.64, representing a decline of 344.81% from a loss of CNY 4,054,817.52 in the previous year[4] - Basic and diluted earnings per share were both CNY -0.07, a decrease of 250.00% from CNY -0.02 in the same period last year[4] - Net profit for Q1 2025 was a loss of CNY 16.57 million, compared to a loss of CNY 4.82 million in Q1 2024, representing an increase in loss of 244.5%[19] - Total operating revenue for Q1 2025 was CNY 309.59 million, a decrease of 26.5% compared to CNY 421.70 million in Q1 2024[18] - Total operating costs for Q1 2025 were CNY 328.99 million, down 23.4% from CNY 429.49 million in Q1 2024[18] Cash Flow - The net cash flow from operating activities decreased by 68.41%, amounting to CNY 35,925,371.50 compared to CNY 113,710,793.08 in the prior year[4] - Cash flow from operating activities for Q1 2025 was CNY 35.93 million, a decrease of 68.4% from CNY 113.71 million in Q1 2024[21] - The total cash inflow from operating activities was CNY 444.76 million in Q1 2025, down 24.6% from CNY 590.51 million in Q1 2024[21] - Net cash flow from investment activities was -18,997,386.13, compared to -13,574,312.17 in the previous period, indicating a decrease of approximately 40%[22] - The net cash flow from financing activities was -32,295,719.80, worsening from -19,740,096.89, indicating a decline of around 63%[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,381,488,129.07, down 3.55% from CNY 1,432,383,524.94 at the end of the previous year[5] - The company's total liabilities decreased to CNY 918.33 million in 2025 from CNY 953.69 million in 2024, a reduction of 3.7%[15] - Total non-current assets slightly decreased to RMB 752,979,938.12 from RMB 754,130,487.07, a change of -0.15%[14] - Short-term borrowings remained relatively stable at RMB 419,024,933.79, a slight decrease of 0.66% from RMB 421,860,760.10[14] - Accounts payable decreased by 3.41% to RMB 281,494,565.69 from RMB 291,484,165.88[14] Shareholder Information - The total number of common shareholders at the end of the reporting period was 25,893[10] - The largest shareholder, Shandong Huifa Investment Co., Ltd., holds 28.41% of the shares, with 44,564,000 shares pledged[10] - Shareholders' equity attributable to the parent company decreased by 3.79%, totaling CNY 432,725,207.92 compared to CNY 449,752,491.39 at the end of the last year[5] - The total equity attributable to shareholders decreased to CNY 432.73 million in 2025 from CNY 449.75 million in 2024, a decline of 3.8%[15] Operational Challenges - The company is facing challenges primarily due to a significant decrease in operating revenue, impacting overall profitability and cash flow[4] - The company reported a significant increase in credit impairment losses, which rose to CNY 4.00 million in Q1 2025 from CNY 2.11 million in Q1 2024[19] - The company reported non-recurring gains and losses totaling CNY 960,277.10 for the period[8] Current Assets - As of March 31, 2025, the total current assets amounted to RMB 628,508,190.95, a decrease of 7.35% from RMB 678,253,037.87 on December 31, 2024[13] - Cash and cash equivalents decreased to RMB 200,670,773.40 from RMB 209,644,700.63, reflecting a decline of 4.65%[13] - Accounts receivable decreased by 14.66% to RMB 221,022,614.43 from RMB 258,825,286.65[13] - Inventory increased by 20.68% to RMB 167,964,301.07 from RMB 139,261,871.25[13]

Financial Performance - The company's revenue for Q1 2025 was ¥443,060,876.63, representing a 5.50% increase compared to ¥419,947,071.70 in the same period last year[5] - Net profit attributable to shareholders decreased by 68.09% to ¥20,645,831.83 from ¥64,704,123.78 year-on-year[5] - Basic and diluted earnings per share dropped by 67.35% to ¥0.16 from ¥0.49 in the same period last year[5] - The company's net profit margin was impacted by increased operating costs, with operating costs representing approximately 90.1% of total revenue[17] - The net profit for the current period is CNY 20,554,596.20, a decrease of 68.2% compared to CNY 64,624,156.39 in the previous period[19] - Operating profit for the current period is CNY 29,182,392.33, down 28.1% from CNY 40,610,952.35 in the previous period[19] - The total comprehensive income attributable to the parent company is CNY 20,645,831.83, a decrease of 68.3% from CNY 64,704,123.78 in the previous period[19] Cash Flow - The net cash flow from operating activities was negative at ¥-38,472,293.47, worsening by 28.14% compared to ¥-30,023,551.71 in the previous year[5] - Cash flow from operating activities shows a net outflow of CNY 38,472,293.47, worsening from a net outflow of CNY 30,023,551.71 in the previous period[20] - Total cash flow from investing activities results in a net outflow of CNY 49,278,526.32, an improvement from a net outflow of CNY 60,329,362.08 in the previous period[20] - Cash flow from financing activities shows a net inflow of CNY 1,574,720.18, compared to a net outflow of CNY 19,861,022.04 in the previous period[21] Assets and Liabilities - Total assets decreased by 3.85% to ¥1,923,982,342.52 from ¥2,001,012,248.66 at the end of the previous year[5] - Total assets decreased from ¥2,001,012,248.66 at the beginning of the period to ¥1,923,982,342.52 at the end of the period, reflecting a reduction of approximately 3.9%[16] - The company’s total liabilities decreased from ¥708,628,324.30 to ¥611,043,821.96, a reduction of about 13.7%[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 13,069[10] - The largest shareholder, Guo Qiuhong, holds 22.68% of the shares, totaling 29,831,200 shares[10] - The company repurchased a total of 2,927,940 shares, accounting for 2.2262% of the total share capital, with a total transaction amount of ¥41,920,670.60[12] Operating Costs and Inventory - Total operating costs rose to ¥400,990,067.63, up 8.1% from ¥370,891,349.36 in the previous period[17] - Cash and cash equivalents decreased from ¥293,821,942.98 to ¥204,845,843.37, a decline of about 30.2%[14] - Accounts receivable decreased from ¥104,307,338.60 to ¥84,433,238.44, a reduction of approximately 19.1%[14] - Inventory decreased from ¥533,434,127.38 to ¥510,211,856.89, reflecting a decline of about 4.3%[14] Government Subsidies - The company received government subsidies amounting to ¥2,021,707.08, an increase of 167.02% compared to ¥757,142.63 in the previous year[8] Audit Status - The company has not undergone an audit for the first quarter report[22]

Financial Performance - The company's operating revenue for 2024 was CNY 795,288,308.90, a decrease of 2.63% compared to 2023 [22]. - Net profit attributable to shareholders for 2024 was CNY 206,791,017.22, down 18.55% from the previous year [22]. - The basic earnings per share for 2024 was CNY 0.25, reflecting a decline of 19.35% compared to 2023 [23]. - The weighted average return on equity decreased to 9.40% in 2024, down 3.33 percentage points from 2023 [23]. - The net cash flow from operating activities for 2024 was CNY 177,925,777.36, a decrease of 19.80% from 2023 [22]. - Total assets at the end of 2024 were CNY 2,982,390,050.39, an increase of 1.04% compared to the end of 2023 [22]. - The net assets attributable to shareholders increased by 6.08% to CNY 2,271,891,202.71 at the end of 2024 [22]. - The company reported a net profit of CNY 112,480,834.45 in the first quarter of 2024, with a significant drop in the fourth quarter resulting in a loss of CNY 22,194,656.44 [26]. - Non-recurring gains and losses totaled CNY 27,910,357.77 for 2024, compared to CNY 10,685,665.36 in 2023 [28]. - The company achieved operating revenue of 795.29 million yuan, a year-on-year decrease of 2.63% [33]. - The net profit attributable to shareholders was 206.79 million yuan, down 18.55% year-on-year [33]. Research and Development - R&D investment reached 100.42 million yuan, accounting for 12.63% of operating revenue, with a year-on-year increase of 28.65% [33]. - The company has established a research and development team of 495 members, including various educational backgrounds, to enhance innovation capabilities [36]. - The company’s R&D investment for the reporting period was CNY 100.42 million, accounting for 12.63% of operating revenue, representing a year-on-year increase of 28.65% [94]. - The number of R&D personnel is 495, making up 40.61% of the total workforce [75]. - The company plans to increase R&D investment, with projected expenditures of CNY 78.06 million and CNY 100.42 million for 2023 and 2024, respectively, representing 9.56% and 12.63% of revenue [116]. - The company is committed to developing innovative drugs with independent intellectual property rights, transitioning from generic to innovative pharmaceuticals [113]. - The company plans to increase investment in the development of synthetic biology technology, peptide drugs, RNA, oligonucleotides, and mid-molecule drugs [89]. Market and Industry Trends - The global pharmaceutical market is projected to grow from approximately $1.6 trillion in 2023 to about $2.2 trillion by 2028, with a compound annual growth rate of 6.6% [38]. - The market for expiring patented drugs is estimated to grow from $51 billion in 2023 to $99 billion by 2028, providing significant opportunities for generic drug companies [38]. - The aging population in China is a key driver for the pharmaceutical market, with the population aged 65 and above expected to grow from 140 million in 2014 to 220 million by 2024, representing approximately 15.64% of the total population [40]. - China's total healthcare expenditure increased from 3.5 trillion yuan in 2014 to 9.1 trillion yuan in 2023, indicating a significant growth in healthcare spending [40]. - The global CRO market size grew from $53.91 billion in 2018 to $82.11 billion in 2023, with a compound annual growth rate (CAGR) of 8.8%, and is projected to reach $106.45 billion by 2026 [41]. - The global CDMO market reached $146.29 billion in 2023 and is expected to grow to approximately $295.95 billion by 2033, with a CAGR of 7.3% from 2024 to 2033 [42]. Corporate Governance - The company has confirmed that all board members attended the board meeting, ensuring governance compliance [4]. - The company has appointed Tianjian Accounting Firm as its auditor, with specific auditors named for the reporting period [21]. - The board of directors and supervisory board have adhered to legal requirements and company regulations in their operations and decision-making processes [120]. - The company has maintained independence from its controlling shareholder in terms of business, personnel, assets, and financial matters [120]. - The company has established an investor relations management system to enhance communication with investors and address their inquiries effectively [122]. - The company has established specialized committees, including an audit committee, nomination committee, remuneration and assessment committee, and strategic committee [137]. Environmental Responsibility - The company has invested RMB 23,579,500 in environmental protection during the reporting period [159]. - The company has established a wastewater treatment system with a capacity of 1,050 tons per day and an organic waste gas RTO incineration device with a capacity of 38,000 cubic meters per hour [161]. - The company has implemented an environmental self-monitoring plan, with all monitored pollutants meeting discharge standards [164]. - The company has a complete environmental risk emergency mechanism and has filed an emergency response plan for sudden environmental pollution events [163]. - There were no administrative penalties related to environmental issues during the reporting period [165]. Shareholder Information - The company plans to distribute a cash dividend of RMB 1 per 10 shares to all shareholders, totaling approximately RMB 82.83 million (including tax) based on the current total share capital of 830,297,145 shares, after accounting for the repurchased shares [6]. - The total number of shares increased from 593,069,389 to 830,297,145 after a capital reserve conversion and cash dividend distribution [193]. - The largest shareholder, Zheng Zhiguo, holds 420,433,703 shares, representing 50.64% of the total shares [198]. - The top five customers accounted for 56.34% and 56.08% of total revenue in 2023 and 2024, indicating a high customer concentration risk [117]. - The company’s total number of ordinary shareholders increased from 30,806 to 42,377 during the reporting period [196]. Strategic Initiatives - The company is focusing on expanding its overseas sales teams, particularly in Europe, Japan, the United States, and South Korea, to strengthen market presence [33]. - The company emphasizes a strategy of integrating intermediates, specialty APIs, and formulations to enhance competitiveness and ensure sustainable development [37]. - The company aims to accelerate the transition from raw materials to formulation development and promote internationalization of formulations [89]. - The company plans to leverage the expiration of numerous innovative drug patents in the coming years to enhance its market position [109]. - The company is committed to increasing R&D investment and improving processes to ensure technological and cost leadership [110].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,555,897,420.93, representing a 14.44% increase compared to CNY 1,359,630,107.92 in the same period last year[4] - Net profit attributable to shareholders was CNY 262,693,988.46, a 33.52% increase from CNY 196,750,299.59 year-over-year[4] - The net profit after deducting non-recurring gains and losses was CNY 245,339,008.85, reflecting a 26.75% increase compared to CNY 193,563,393.28 in the previous year[4] - Basic earnings per share increased by 30.77% to CNY 0.34 from CNY 0.26 in the previous year[4] - Net profit for Q1 2025 was ¥265,346,631.68, compared to ¥199,394,203.24 in Q1 2024, representing a growth of 33.0%[21] - Earnings per share for Q1 2025 was ¥0.34, an increase from ¥0.26 in Q1 2024[22] Cash Flow - The net cash flow from operating activities was CNY 325,436,576.41, a significant improvement from a negative cash flow of CNY -103,015,204.72 in the same period last year[4] - The net cash inflow from operating activities was CNY 325,436,576.41, a significant improvement compared to a net outflow of CNY -103,015,204.72 in the previous period[26] - Total cash inflow from operating activities was CNY 1,675,964,763.10, compared to CNY 1,338,517,032.54 in the previous period[26] - The total cash outflow from operating activities was CNY 1,350,528,186.69, down from CNY 1,441,532,237.26 year-over-year[26] - Cash received from sales of goods and services in Q1 2025 was ¥1,553,068,945.87, compared to ¥1,259,711,163.24 in Q1 2024, indicating a growth of 23.3%[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 8,703,936,437.11, a slight decrease of 0.09% from CNY 8,711,353,802.58 at the end of the previous year[5] - Total current assets amounted to ¥7,083,603,393.61, slightly down from ¥7,113,167,895.65, indicating a decrease of approximately 0.4%[15] - Total liabilities decreased to ¥4,006,519,934.87 from ¥4,295,367,049.28, a reduction of 6.7%[17] - The company's total non-current assets were ¥1,620,333,043.50, up from ¥1,598,185,906.93, reflecting a growth of 1.4%[16] Shareholder Equity - Shareholders' equity attributable to the parent company increased by 6.43% to CNY 4,600,789,025.63 from CNY 4,322,901,433.91 at the end of the previous year[5] Non-Recurring Items - Non-recurring gains and losses amounted to CNY 17,354,979.61 after tax, with significant contributions from government subsidies and other non-operating income[7] Investment Activities - Total cash inflow from investment activities amounted to CNY 561,711,257.38, up from CNY 119,530,262.54 year-over-year[26] - The net cash flow from investment activities was CNY 273,556,397.82, recovering from a net outflow of CNY -123,250,937.60 in the prior period[26] Financial Management - The company reported a financial expense of -¥17,442,521.28 in Q1 2025, compared to -¥974,689.07 in Q1 2024, indicating a significant improvement in financial management[21] Operational Insights - The increase in operating revenue and net profit was primarily driven by sales growth and the resulting economies of scale[8] - The company has no significant new product launches or technological developments reported in the current quarter[13] - There are no updates on market expansion or mergers and acquisitions during this reporting period[13] - The company has not disclosed any new strategic initiatives in the recent earnings call[13] - There are no significant changes in the shareholding structure or major shareholders participating in financing activities[12]

Financial Performance - The company's revenue for Q1 2025 reached CNY 2,585,144,857.99, representing a 74.81% increase compared to CNY 1,478,832,096.46 in the same period last year[5]. - Net profit attributable to shareholders decreased by 60.07% to CNY 26,858,423.90 from CNY 67,266,929.29 year-on-year[5]. - Basic and diluted earnings per share fell by 70.05% to CNY 0.1132 from CNY 0.3780 in the previous year[6]. - The decline in net profit is attributed to intensified competition in the photovoltaic industry and a decrease in processing fees[8]. - The company reported a decrease of 37.79% in net profit attributable to shareholders after deducting non-recurring gains and losses[5][8]. - The net profit for the first quarter of 2025 was 26,858,423.90, a decrease from 67,266,929.29 in the same period of 2024, representing a decline of approximately 60%[22]. - The company reported a total comprehensive income of -4,653,806.97, a significant drop from 63,564,810.95 in the first quarter of 2024[23]. Assets and Liabilities - Total assets increased by 9.05% to CNY 11,730,080,031.53 from CNY 10,757,027,275.11 at the end of the previous year[6]. - Total liabilities amounted to RMB 7,956,608,257.28, compared to RMB 7,005,541,475.33, reflecting an increase of approximately 14%[18]. - The company's equity attributable to shareholders was RMB 3,773,471,774.25, slightly up from RMB 3,751,485,799.78[18]. Cash Flow - The net cash flow from operating activities was negative at CNY -992,896,181.62, compared to CNY -594,982,286.89 in the same period last year, indicating increased procurement payments due to business expansion[5][8]. - The net cash flow from financing activities was 1,392,133,557.24, an increase from 824,891,469.24 in the first quarter of 2024, showing a growth of about 68.7%[27]. Operating Revenue and Costs - Total operating revenue for Q1 2025 reached RMB 2,585,144,857.99, a significant increase of 75% compared to RMB 1,478,832,096.46 in Q1 2024[21]. - Total operating costs for Q1 2025 were RMB 2,576,521,647.95, up from RMB 1,445,698,364.12 in Q1 2024, reflecting a 78% increase[21]. - The company reported a net profit margin improvement, with total operating costs growing at a slower rate than revenue[21]. Shareholder Information - The company has a total of 22,909 ordinary shareholders as of the end of the reporting period[10]. - The top shareholder, Wang Xianli, holds 37.1% of the shares, totaling 88,118,640 shares[11]. Research and Development - Research and development expenses increased to 23,801,068.65, up from 19,658,969.46, reflecting a growth of about 21.5% year-over-year[22]. Future Outlook - Future outlook includes continued focus on market expansion and potential new product development strategies[13].

Financial Performance - The company's revenue for Q1 2025 reached ¥8,602,240,027.91, representing an increase of 11.07% compared to ¥7,744,804,604.28 in the same period last year[4] - Net profit attributable to shareholders was ¥455,862,422.17, a significant increase of 57.55% from ¥289,348,487.81 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥396,749,250.19, up 51.83% from ¥261,306,973.35 in the previous year[4] - Basic earnings per share rose to ¥0.27, reflecting a 58.82% increase compared to ¥0.17 in the same period last year[4] - The total profit for the period was ¥596,686,190.91, marking a 72.32% increase from ¥346,267,196.58 in the previous year[7] - Operating profit for the current period was ¥594,895,048.03, representing a significant increase of 71.43% from ¥346,968,163.30 in the previous period[17] - Net profit for the current period was ¥456,526,563.63, a rise of 57.94% compared to ¥289,267,722.86 in the prior period[17] - Total comprehensive income amounted to CNY 510,924,979.94, a significant increase from CNY 260,903,642.31 in the previous period[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥46,469,701,601.63, a slight increase of 0.99% from ¥46,014,173,064.47 at the end of the previous year[4] - The equity attributable to shareholders increased by 2.71% to ¥19,336,648,107.86 from ¥18,826,387,269.38 at the end of the previous year[4] - Total liabilities decreased slightly to ¥27,072,673,388.46 from ¥27,128,069,831.24, a reduction of 0.21%[14] Cash Flow - The net cash flow from operating activities decreased by 12.35% to ¥1,365,406,591.51 from ¥1,557,837,879.15 in the same period last year[4] - Net cash flow from financing activities decreased by 81.88% to ¥267,605,322.80 compared to ¥1,476,912,312.82 in the same period last year, primarily due to a reduction in bank borrowings[7] - Cash inflow from operating activities totaled CNY 10,174,457,452.22, slightly decreasing from CNY 10,200,066,749.22 in the previous period[19] - Cash outflow from investing activities was CNY 1,435,538,654.27, compared to CNY 1,505,203,582.07 in the prior period[20] - The ending cash and cash equivalents balance was CNY 6,021,588,750.01, down from CNY 7,629,672,116.98 in the previous period[20] Shareholder Information - The total number of common shareholders at the end of the reporting period was 78,035[9] - Major shareholder Yuan Yongfeng holds 13.04% of shares, with 222,388,153 shares pledged[9] - Major shareholder Yuan Yonggang holds 11.85% of shares, with 202,226,196 shares pledged[9] - The company plans to issue shares to controlling shareholders Yuan Yonggang and Yuan Yongfeng, raising up to RMB 1.5 billion, adjusted to RMB 1.404 billion after expenses[11] Other Income and Expenses - The company reported a significant increase in other income, which rose by 68.55% to ¥77,548,707.75 due to increased government subsidies related to assets[7] - Research and development expenses for the current period were ¥275,326,675.54, up from ¥253,417,603.85, indicating a growth of 8.63%[17] - Other comprehensive income after tax for the current period was ¥54,398,416.31, compared to a loss of ¥28,364,080.55 in the prior period[17] Audit and Approvals - The company did not undergo an audit for the first quarter report[21] - The company has received approval from the Shenzhen Stock Exchange for the issuance of shares on March 10, 2025[11]

Revenue and Profitability - Revenue for Q1 2025 was CNY 595,310,921.43, a decrease of 2.16% compared to CNY 608,465,650.49 in the same period last year[5] - Net profit attributable to shareholders increased by 10.82% to CNY 7,189,294.21 from CNY 6,487,479.20 year-on-year[5] - Net profit excluding non-recurring gains and losses rose by 42.87% to CNY 5,562,551.64, driven by improved inventory management[5] - Basic and diluted earnings per share increased by 11.69% to CNY 0.0172 per share[5] - Operating profit for Q1 2025 was ¥7.55 million, down 22.4% from ¥9.75 million in Q1 2024[17] - The company reported a total comprehensive income of ¥10.47 million for Q1 2025, down from ¥15.48 million in Q1 2024[18] - The net profit for Q1 2025 was a loss of CNY 3,282,610.56, compared to a loss of CNY 2,252,822.09 in Q1 2024, indicating a deterioration in profitability[26] Cash Flow and Liquidity - Net cash flow from operating activities decreased significantly by 75.88% to CNY 5,861,919.27, attributed to increased inventory from new business orders[5] - Cash flow from operating activities for Q1 2025 was ¥5.86 million, significantly lower than ¥24.30 million in Q1 2024[20] - The company generated net cash flow from investing activities of ¥14.42 million in Q1 2025, a recovery from a negative cash flow of ¥80.99 million in Q1 2024[21] - In Q1 2025, the net cash flow from operating activities was ¥45,019,053.98, a significant improvement compared to a net outflow of ¥14,566,193.72 in Q1 2024[28] - The net cash flow from financing activities was negative at -¥1,214,147.88, a decline from a positive net flow of ¥28,718,671.40 in Q1 2024[28] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,300,795,657.43, up 5.46% from CNY 4,078,091,039.81 at the end of the previous year[5] - Total liabilities increased to ¥1,367,680,785.93 from ¥1,156,442,968.02, reflecting a growth of approximately 18.2%[15] - The company's total liabilities increased to CNY 650,966,494.19 as of March 31, 2025, from CNY 475,482,000.94 at the end of 2024, representing a rise of approximately 36.73%[23] - The total assets of the company as of March 31, 2025, were ¥4,300,795,657.43, compared to ¥4,078,091,039.81 at the end of 2024, marking an increase of about 5.4%[15] Inventory and Receivables - The company's inventory stood at ¥605,518,282.91, which is an increase from ¥572,219,131.25, showing a growth of approximately 5.8%[13] - The company's inventory decreased slightly to CNY 17,570,006.18 from CNY 18,596,888.69, a decline of approximately 5.50%[22] - The company reported a significant increase in other receivables, which rose to ¥157,252,131.85 from ¥151,238,732.87, reflecting a growth of about 4.0%[13] - The company reported a significant increase in other receivables, totaling CNY 671,090,688.73 as of March 31, 2025, compared to CNY 641,633,404.35 at the end of 2024, an increase of about 4.59%[22] Operational Efficiency - The decrease in revenue was primarily due to a slight decline in overseas sales of motor and drive products[7] - The company maintains a focus on improving operational efficiency and inventory management to enhance profitability[7] - Research and development expenses for Q1 2025 were ¥60.39 million, slightly up from ¥59.36 million in Q1 2024[17] - Research and development expenses for Q1 2025 were CNY 2,055,702.09, down from CNY 2,566,268.77 in Q1 2024, reflecting a decrease of about 19.83%[26] Shareholders' Equity - Shareholders' equity attributable to the parent company increased slightly by 0.36% to CNY 2,923,536,166.23[5] - The company's total equity increased to ¥2,933,114,871.50 from ¥2,921,648,071.79, reflecting a growth of approximately 0.4%[15] - The total equity of the company as of March 31, 2025, was CNY 1,897,604,174.36, a slight decrease from CNY 1,900,886,784.92 at the end of 2024[24]

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,063,814,130.77, a decrease of 5.95% compared to CNY 1,131,146,576.85 in the same period last year[4] - Net profit attributable to shareholders increased by 13.72% to CNY 377,399,335.41 from CNY 331,878,544.74 year-on-year[4] - Basic and diluted earnings per share rose by 14.10% to CNY 0.89 from CNY 0.78 in the previous year[4] - Total revenue for Q1 2025 was approximately ¥1,063.81 million, a decrease of 5.95% compared to ¥1,131.15 million in Q1 2024[18] - Net profit for Q1 2025 reached approximately ¥390.16 million, an increase of 15.66% compared to ¥337.33 million in Q1 2024[19] - Operating profit for Q1 2025 was approximately ¥510.95 million, up 25.8% from ¥406.14 million in Q1 2024[19] - The total comprehensive income amounted to approximately ¥390.3 million, compared to ¥337.3 million in the previous period, reflecting an increase of around 15.7%[20] Assets and Equity - Total assets at the end of the reporting period reached CNY 21,680,755,459.60, reflecting an 18.68% increase from CNY 18,268,087,176.51 at the end of the previous year[5] - Current assets totaled approximately ¥5.85 billion as of March 31, 2025, compared to ¥4.96 billion at the end of 2024, reflecting a growth of 17.93%[14] - The company’s total equity increased to approximately ¥10.88 billion as of March 31, 2025, from ¥10.44 billion at the end of 2024, reflecting a growth of 4.23%[15] - Shareholders' equity attributable to shareholders increased by 4.75% to CNY 8,529,812,726.73 from CNY 8,143,131,912.84[5] Cash Flow - The net cash flow from operating activities was CNY 413,218,845.68, down 3.94% from CNY 430,148,008.82 in the same period last year[4] - Cash flow from operating activities generated a net amount of approximately ¥413.2 million, slightly down from ¥430.1 million in the previous period, a decrease of about 3.1%[23] - Cash flow from investing activities resulted in a net outflow of approximately ¥3.21 billion, compared to a net outflow of ¥333.4 million in the previous period, indicating a significant increase in investment activities[24] - Cash flow from financing activities generated a net inflow of approximately ¥3.11 billion, compared to a net inflow of ¥304.2 million in the previous period, showing a substantial increase in financing efforts[24] Shareholder Information - The total number of common shareholders at the end of the reporting period was 26,122[9] - The largest shareholder, Ming Zaiyuan, holds 41.07% of the shares, amounting to 174,090,367 shares, with 50,600,000 shares pledged[9] Liabilities - Non-current liabilities increased to approximately ¥7.32 billion as of March 31, 2025, from ¥4.43 billion at the end of 2024, marking a rise of 65.5%[15] - The company’s long-term borrowings rose to approximately ¥6.09 billion as of March 31, 2025, compared to ¥3.24 billion at the end of 2024, indicating a growth of 88.5%[15] Other Financial Metrics - The weighted average return on equity improved to 4.53%, an increase of 0.10 percentage points from 4.43%[5] - Non-recurring gains and losses totaled CNY 19,411,245.41 after accounting for tax and minority interests[7] - The ending balance of cash and cash equivalents was approximately ¥2.80 billion, down from ¥3.19 billion in the previous period, reflecting a decrease of about 12.4%[24] - The company reported cash received from sales of goods and services of approximately ¥1.06 billion, slightly down from ¥1.11 billion in the previous period, a decrease of about 3.5%[23] - The company absorbed investments totaling approximately ¥35 million from minority shareholders, indicating continued interest from investors[24] - The company received cash from investment activities totaling approximately ¥58.4 million, compared to ¥6.4 million in the previous period, indicating a significant increase in cash inflow from investments[24]